BNBX logo

BNBX BNB Plus Corp.

NASDAQ Global Market · Biotechnology · Healthcare

$0.16
+0.00 (+0.00%)

BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymati…

Market Cap: $210.5Kwww.bnbx.io

Price

No data yet.

Social Signal Score

50
5d
50
1 mentions
30d
50
1 mentions
60d
50
1 mentions
90d
50
1 mentions
news: 1

Revenue

$1.02M+116.61%
$199.4K$531.8K$864.2K$1.20M
Jun 2024Mar 2026

Analyst Estimates

FY2025
$-360.00
$-360.00$-360.00
1 analysts
FY2026
$-82.50
$-82.50$-82.50
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Clay D. Shorrock
Sector
Healthcare
Industry
Biotechnology
Employees
26
Beta
0.55
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-49.65
www.bnbx.io